vials containing 2 mg NAHA plus anti-ageing complex (vitamins, minerals and amino acids)
■Empty sterile syringes: 20 cc luer lock ■Three-way valve with luer lock connection ■Cannula: 25 G/40 mm ■Lidocaine and adrenaline vials 1 : 100 000.
Patients Group 1 Five patients were treated with a combination of two syringes of ALIAXIN® SR and two syringes of VISCODERM® 2.0%.
Group 2 Five patients were treated with a combination of two syringes of ALIAXIN® SR and two syringes of VISCODERM® SKINKO’.
The choice of products to inject was based on the degree of skin ageing and the desired results: volume or deep hydration.
The blend For the first mixture — in a sterile environment — the contents of two syringes of ALIAXIN® SR and two syringes of VISCODERM® 2.0% were transferred into the 20 cc sterile syringe, after which the author connected the 20 cc syringe containing the products to an empty 20 cc syringe using a three-way valve. With one of the valves closed, the product is expelled from one syringe to the other. This action is repeated until the products are completely mixed. The same process is used for the mixture between ALIAXIN® SR and VISCODERM® SKINKO’. This technique is quite rapid and easy to carry out, requiring approximately 5 minutes more than injecting directly from the pre-filled syringes. After having prepared the solution and injected an
anaesthetic with vasoconstrictor at the entrance points, the solution, which is much more fluid compared with traditional HA, may now be injected. When the implant is completed, a delicate massage is recommended in order to distribute the product homogeneously over the treated area.
Results and conclusions Using the methods described by the author, the result achieved in both groups was a uniform distribution of the product without the negative aesthetic ‘pipe organ’
An example from patient group 2 — treated with a combination of ALIAXIN® SR and VISCODERM® SKINKO’ — (A) before and (B) after treatment
effect. The quantity of solution used has resulted in an optimum facial modelling effect with an immediate improvement in turgor and radiance of the skin. As predicted by the author, the volumising effect was obtained in the first group treated with ALIAXIN® and VISCODERM® 2.0%, while the results of the second group treated with ALIAXIN® SR and VISCODERM® SKINKO’ showed an immediate improvement in hydration and radiance. The author would like to emphasise that there were
no reported patient complaints with regard to pain, and all treatments were recorded without side-effects both immediately after the treatment and in the months that follow.
Please visit us at EADV Prague 2012, booth 42. For further information email:
info@viscoderm.com
Point of injection and infiltration direction
Hyaluronic acid distribution
HYDROLIFT™ ACTION: cannula technique
prime-journal.com | September 2012
❚
57
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84